Colgan T - Search Results

1

How important is removal of the parametrium at surgery for carcinoma of the cervix?

Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P. Covens A, et al. Among authors: colgan t. Gynecol Oncol. 2002 Jan;84(1):145-9. doi: 10.1006/gyno.2001.6493. Gynecol Oncol. 2002. PMID: 11748991

2

Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.

Grisaru DA, Covens A, Franssen E, Chapman W, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B. Grisaru DA, et al. Among authors: colgan t. Cancer. 2003 Apr 15;97(8):1904-8. doi: 10.1002/cncr.11269. Cancer. 2003. PMID: 12673716 Free article.

3

Differences in the morbidity of radical hysterectomy between gynecological oncologists.

Covens A, Rosen B, Gibbons A, Osborne R, Murphy J, DePetrillo A, Lickrish G, Shaw P, Colgan T. Covens A, et al. Among authors: colgan t. Gynecol Oncol. 1993 Oct;51(1):39-45. doi: 10.1006/gyno.1993.1243. Gynecol Oncol. 1993. PMID: 8244172

4

Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.

Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P. Covens A, et al. Among authors: colgan t. Gynecol Oncol. 2001 May;81(2):133-7. doi: 10.1006/gyno.2001.6158. Gynecol Oncol. 2001. PMID: 11330939

5

Does histology influence prognosis in patients with early-stage cervical carcinoma?

Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B. Grisaru D, et al. Among authors: colgan t. Cancer. 2001 Dec 15;92(12):2999-3004. doi: 10.1002/1097-0142(20011215)92:12<2999::aid-cncr10145>3.0.co;2-1. Cancer. 2001. PMID: 11753977

6

The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia.

Colgan TJ, Lickrish GM. Colgan TJ, et al. Gynecol Oncol. 1990 Feb;36(2):246-9. doi: 10.1016/0090-8258(90)90182-k. Gynecol Oncol. 1990. PMID: 2298414

7

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status.

Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B. Colgan TJ, et al. Am J Surg Pathol. 2001 Oct;25(10):1283-9. doi: 10.1097/00000478-200110000-00009. Am J Surg Pathol. 2001. PMID: 11688463

8

Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy.

Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B. Colgan TJ, et al. Gynecol Oncol. 2002 Jun;85(3):397-403. doi: 10.1006/gyno.2002.6638. Gynecol Oncol. 2002. PMID: 12051865 Clinical Trial.

9

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Finch A, et al. Gynecol Oncol. 2006 Jan;100(1):58-64. doi: 10.1016/j.ygyno.2005.06.065. Epub 2005 Aug 31. Gynecol Oncol. 2006. PMID: 16137750

10

Colposcopy of adenocarcinoma in situ and invasive adenocarcinoma of the cervix.

Lickrish GM, Colgan TJ, Wright VC. Lickrish GM, et al. Among authors: colgan tj. Obstet Gynecol Clin North Am. 1993 Mar;20(1):111-22. Obstet Gynecol Clin North Am. 1993. PMID: 8332305 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters